Company Name : Taro Pharmaceutical Industries Ltd.

Tuesday, October 30, 2018 9:15AM IST (3:45AM GMT)

(BW)(NY-TARO-PHARMACEUTICAL)

Taro to Announce Second Quarter Results on November 5, 2018


Earnings Call to be Conducted Tuesday, November 6 at 8:00 am EST


HAWTHORNE, N.Y., United States

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2018, on Monday, November 5, 2018.

 

The Company will conduct an earnings call at 8:00 am EST on Tuesday, November 6, 2018, where senior management will discuss the Company’s performance and answer questions from participants.

 

The earnings release will be accessible on Taro’s website at www.taro.com.

 

Earnings Call (8:00 am EST on Tuesday, November 6, 2018)

 

To participate in this conference call, please dial the numbers provided below five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.taro.com. A transcript of this earnings call will also be available on the website.

 
 

Summary of events

Event     Date and time     Telephone number/ website
Earnings release     November 5, 2018 (AMC)    

www.taro.com

Earnings conference call     8:00 am EST

November 6, 2018

   

Participant Toll-Free Dial-In Number: +1 (844) 421-0601

 

Participant International Dial-In Number: +1 (716) 247-5800

 

Conference ID: 2871389

 

 

 

Via audio webcast, details of which will be made available on www.taro.com

Replay of conference call     November 6, 2018 to

November 18, 2018

   

+ 1 (855) 859-2056 or +1 (404) 537-3406

 

Conference ID: 2871389

 

 

 

Via audio webcast playback, details of which will be made available on www.taro.com

             

About Taro

 

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

 

 


Click here for Media Contact Details
CONTACTS :

Taro Pharmaceutical Industries Ltd.
Mariano A. Balaguer
VP, CFO
(914) 345-9001
Mariano.Balaguer@taro.com
or
William J. Coote
AVP, Business Finance, Treasurer and Investor Relations
(914) 345-9001
William.Coote@taro.com


More News from Taro Pharmaceutical Industries Ltd.

01/10/2018 9:50AM

टैरो ने नोवाबायोटिक्स के साथ करार खत्म किया

टैरो फार्मास्यूटिकल इंडस्ट्रीज लिमिटेड (एनवाईएसई:टैरो) (“टैरो” या “कंपनी”) ने आज एलान किया कि उसने नोवाबायोटिक्स के साथ लाइसेंस करार खत्म कर दिया है जो ओनीकोमिकोसिस औषधि नोवैक्सैटिन ...

29/09/2018 2:06PM

Taro Terminates Agreement with NovaBiotics

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) announced today that it has terminated the license agreement with NovaBiotics for the onychomycosis drug, ...

11/08/2018 12:15PM

टैरो ने जून 2018 में समाप्त तिमाही के वित्तीय परिणाम मुहैया कराए

टैरो फार्मास्यूटिकल इंडस्ट्रीज लिमिटेड (एनवाईएई:टैरो) (“टैरो या “कंपनी”) ने  आज 30 जून 2018 को समाप्त तिमाही के अनअंकेक्षित वित्तीय परिणाम मुहैया कराए।    30 जून 2018 ...

Similar News

30/10/2018 9:30AM

NEC and Transgene Announce a Collaboration in the Field of Individualized Cancer Immunotherapy, Leveraging NEC's AI and Transgene’s myvac™ Platform

NEC Corporation (NEC)(TOKYO:6701) and Transgene (Euronext Paris:TNG) today announced the signing of a Memorandum of Understanding (MOU) for a strategic collaboration aimed at the treatment of solid cancers. The ...

No Image

29/10/2018 3:15PM Image

BigMuscles Nutrition Releases TVC With Brand Ambassador Ranveer Singh

BigMuscles Nutrition, one of the country's leading nutritional supplement brands, has released its TVC with their brand ambassador and Bollywood superstar Ranveer Singh. A powerhouse performer, Ranveer Singh has wowed ...